The monoclonal antibody denosumab prevents fractures and increases survival in breast cancer patients receiving aromatase inhibitors. Credit: Nancy R. Gough, BioSerendipity

New Options for Limiting the Side Effects of Anti-Estrogen Breast Cancer Therapy

Clinical trial results show that the monoclonal antibody denosumab is effective in preventing fractures associated with anti-estrogen therapy and extends disease-free survival of breast cancer patients.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Nancy R. Gough, PhD

Nancy R. Gough, PhD

Scientist, editor, and writer with a PhD in Pharmacology